Nitric oxide and the pathogenesis of heart muscle disease.
作者信息
de Belder A J, Radomski M W, Martin J F, Moncada S
机构信息
Department of Cardiology, King's College Hospital, London, UK.
出版信息
Eur J Clin Invest. 1995 Jan;25(1):1-8. doi: 10.1111/j.1365-2362.1995.tb01517.x.
Abstract
摘要
相似文献
1
Nitric oxide and the pathogenesis of heart muscle disease.
Eur J Clin Invest. 1995 Jan;25(1):1-8. doi: 10.1111/j.1365-2362.1995.tb01517.x.
2
[Nitric oxide: a nonadrenergic, noncholinergic mediator in the digestive system].
Gastroenterol Hepatol. 1995 Jun-Jul;18(6):334-9.
3
Nitric oxide and synaptic function.
Annu Rev Neurosci. 1994;17:153-83. doi: 10.1146/annurev.ne.17.030194.001101.
4
Nitric oxide and vascular disease.一氧化氮与血管疾病。
N Engl J Med. 1995 Jul 27;333(4):251-3. doi: 10.1056/NEJM199507273330410.
5
Nitric oxide: a physiologic messenger molecule.一氧化氮：一种生理信使分子。
Annu Rev Biochem. 1994;63:175-95. doi: 10.1146/annurev.bi.63.070194.001135.
6
Distribution of NADPH diaphorase-reactive nerves in the human female genital organ.
Acta Obstet Gynecol Scand. 1995 Mar;74(3):171-6. doi: 10.3109/00016349509008933.
7
Nitric oxide--from mediator to medicines.一氧化氮——从介质到药物
J R Coll Physicians Lond. 1994 May-Jun;28(3):209-19.
8
Regulation of vascular homeostasis by nitric oxide.一氧化氮对血管稳态的调节。
Thromb Haemost. 1993 Jul 1;70(1):36-41.
9
Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine.一氧化氮（NO）合成抑制对甲基苯丙胺刻板行为和运动刺激作用超敏反应发展的影响。
Brain Res. 1995 May 15;679(2):200-4. doi: 10.1016/0006-8993(95)00207-7.
10
Distribution of constitutive nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in murine telogen and anagen skin.组成型一氧化氮合酶免疫反应性和NADPH-黄递酶活性在小鼠休止期和生长期皮肤中的分布
J Invest Dermatol. 1994 Jul;103(1):112-5. doi: 10.1111/1523-1747.ep12391865.
引用本文的文献
1
Leptin levels in Henoch-Schönlein purpura.过敏性紫癜中的瘦素水平。
Clin Rheumatol. 2007 Mar;26(3):371-5. doi: 10.1007/s10067-006-0363-6. Epub 2006 Jul 1.
2
Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.通过诱导型一氧化氮合酶进行基因治疗可通过环氧化酶-2依赖性机制预防心肌梗死。
Circ Res. 2003 Apr 18;92(7):741-8. doi: 10.1161/01.RES.0000065441.72685.29.
3
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.缺血预处理的晚期阶段因诱导型一氧化氮合酶基因的靶向破坏而被消除。
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11507-12. doi: 10.1073/pnas.96.20.11507.
Zotero 插件